mrk

Merck Acquires Rigontec for $550 Million

Merck Acquires Rigontec for $550 Million

Merck & Co. Inc. (NYSE: MRK) announced today its acquisition of German biotech start-up, Rigontec for approximately €464 million or $550 million to further advance studies and research in cancer treatment development.Merck agreed to pay &eu..

As CEOs Resign From White House' Business Council, the President Shuts it Down

As CEOs Resign From White House' Business Council, the President Shuts it Down

In the recent events of that occurred in Charlottesville, VA and President Trump’s response to the events has led to several CEOs in the White House' business council to resign. Major CEOs from companies such as Merck & Co. (NYSE: MRK)..